Area of research
Physiology · Nephrology
Research interest
Research interests include Physical Activity and Health, Parathyroid Disorders and Treatments, Cancer survivorship and care, and Health Systems, Economic Evaluations, Quality of Life.
Impact of COVID-19-related healthcare changes on antibiotic resistance in clinical Escherichia coli isolates: interrupted time series analyses in Scotland, UK.
Antibiotic prescribing for care-home residents: a population-based, cross-classified multilevel analysis in Scotland, UK.
Impact of COVID-19 related healthcare changes on antibiotic resistance in clinical<i>Escherichia coli</i>isolates: interrupted time series analyses in Scotland, UK
Patients’ and Clinicians’ Experiences Using a Real-Time Remote Monitoring System for Chemotherapy Symptom Management (ASyMS): Qualitative Study
Patients' and Clinicians' Experiences Using a Real-Time Remote Monitoring System for Chemotherapy Symptom Management (ASyMS): Qualitative Study.
The implications of competing risks and direct treatment disutility in cardiovascular disease and osteoporotic fracture: risk prediction and cost effectiveness analysis.
Association of bradykinin receptor 2 (BDKRB2) variants with physical performance and muscle mass: Findings from the LACE sarcopenia trial.
iDiabetes platform-enhanced phenotyping of patients with diabetes for precision diagnosis, prognosis and treatment: study protocol for a cluster-randomised controlled study in Tayside, Scotland.
Patients' and Clinicians' Perceptions of the Clinical Utility of Predictive Risk Models for Chemotherapy-Related Symptom Management: Qualitative Exploration Using Focus Groups and Interviews.
Community antibiotic prescribing in patients with COVID-19 across three pandemic waves: a population-based study in Scotland, UK.
The iDiabetes Platform: Enhanced Phenotyping of Patients with Diabetes for Precision Diagnosis, Prognosis and Treatment - study protocol for a cluster-randomised controlled study in Tayside, Scotland
Derivation and validation of the CFracture competing risk fracture prediction tool compared with QFracture in older people and people with comorbidity: a population cohort study.
Multicenter Randomized Trial Assessing MRI and Image-guided Biopsy for Suspected Prostate Cancer: The MULTIPROS Study.
External validation of the QLifetime cardiovascular risk prediction tool: population cohort study.
Age and cancer type: associations with increased odds of receiving a late diagnosis in people with advanced cancer.
Free-text analysis of general practice out-of-hours (GPOOH) use by people with advanced cancer: an analysis of coded and uncoded free-text data.
Quantifying the impact of taking medicines for primary prevention: a time-trade off study to elicit direct treatment disutility in the UK.
ACE I/D genotype associates with strength in sarcopenic men but not with response to ACE inhibitor therapy in older adults with sarcopenia: Results from the LACE trial.
Activin type I receptor polymorphisms and body composition in older individuals with sarcopenia-Analyses from the LACE randomised controlled trial.
Community Antibiotic Prescribing in Patients with COVID-19 Across Three Pandemic Waves: A Population-Based Cohort Study
Patients’ and Clinicians’ Experiences Using a Real-Time Remote Monitoring System for Chemotherapy Symptom Management (ASyMS): Qualitative Study (Preprint)
Patients’ and Clinicians’ Perceptions of the Clinical Utility of Predictive Risk Models for Chemotherapy-Related Symptom Management: Qualitative Exploration Using Focus Groups and Interviews (Preprint)
Effect of perindopril or leucine on physical performance in older people with sarcopenia: the LACE randomized controlled trial
Effect of perindopril or leucine on physical performance in older people with sarcopenia: the LACE randomized controlled trial.
Patient outcomes following AKI and AKD: a population-based cohort study.
Predictive performance of a competing risk cardiovascular prediction tool CRISK compared to QRISK3 in older people and those with comorbidity: population cohort study.
Effect of competing mortality risks on predictive performance of the QFracture risk prediction tool for major osteoporotic fracture and hip fracture: external validation cohort study in a UK primary care population.
Death from cancer: frequent unscheduled care.
Community prescribing trends and prevalence in the last year of life, for people who die from cancer.
Clinical improvement of DM1 patients reflected by reversal of disease-induced gene expression in blood.